Marketing-authorisation holder · United States

Bionpharma

United States14 medicines1 country

14 medicines in 1 country, as authorisation holder.

Group structure

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Every medicine in the registers under its name, current ones first.

14 medicines

Medicine	Substance	Country	Status	Authorised
ANESTACON2% · Jelly	Lidocaine	United States	Not marketed	1974
AZITHROMYCIN250mg base \| 500mg base \| 600mg base · Tablet	Azithromycin	United States	Marketed	2005
CETIRIZINE HYDROCHLORIDE HIVES RELIEF10mg \| 5mg · Capsule	Cetirizine	United States	Marketed	2009
DICLOFENAC POTASSIUM25mg · Capsule	Diclofenac	United States	Marketed	2016
ETRAVIRINE100mg \| 200mg \| 25mg · Tablet	Etravirine	United States	Marketed	2021
FLUVOXAMINE MALEATE100mg \| 25mg \| 50mg · Tablet	Fluvoxamine	United States	Marketed	2000
GLYCOPYRROLATE1mg/5ml · Solution	Glycopyrronium	United States	Marketed	2021
LORATADINE10mg · Capsule	Loratadine	United States	Marketed	2016
METHYLPHENIDATE HYDROCHLORIDE10mg \| 20mg \| 5mg · Tablet	Methylphenidate	United States	Marketed	1977
MIDOL LIQUID GELS200mg · Capsule	Ibuprofen	United States	Marketed	2002
NICARDIPINE HYDROCHLORIDE20mg \| 30mg · Capsule	Nicardipine	United States	Marketed	1996
NIMODIPINE30mg · Capsule	Nimodipine	United States	Marketed	2007
PARICALCITOL1mcg \| 2mcg \| 4mcg · Capsule	Paricalcitol	United States	Marketed	2013
STAVZOR125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · Capsule, delayed release	Valproic acid	United States	Not marketed	2008